指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

新冠肺炎重症ARDS静脉-静脉体外膜氧合国际德尔菲专家共识

Expert consensus statement on venovenous extracorporeal membrane oxygenation ECMO for COVID-19 severe ARDS: an international Delphi study.
指南 / 共识 · Ann Intensive Care · 2023-05-02
一句话结论22名国际专家经改良德尔菲法形成14条共识,覆盖患者选择、ECMO临床管理、运行后勤与伦理,指导未来大流行中的ECMO实践。

针对COVID-19相关重症ARDS的静脉-静脉体外膜氧合(VV-ECMO)管理高质量证据不足、资源稀缺时分配缺乏共识的问题,22名国际ECMO专家采用改良德尔菲法和名义组技术,经三轮面对面会议和匿名投票形成共识。第一阶段获得52个争议问题,第二阶段经去重审核为9个领域32个问题(验证率超过75%),第三阶段用25个问题形成14条声明、6个问题未达成共识,第四阶段两轮投票后14条声明达成共识,归入患者选择、ECMO临床管理、运行与后勤管理、伦理四个领域。作者指出COVID-19出现三年后对ECMO作用的理解已有进展但仍不完整,共识旨在指导下一代ECMO从业者应对未来大流行。

要点

  • 共识由22名国际ECMO专家制定,采用改良德尔菲法和名义组技术,经三轮面对面会议和匿名投票。
  • 流程分五阶段:识别知识缺口、验证、声明形成、投票、起草。
  • 第一阶段获52个争议问题,第二阶段审核为9个领域32个问题,验证率超过75%。
  • 第三阶段25个问题形成14条声明,6个问题未达成共识;第四阶段两轮投票后14条声明达成共识。
  • 共识覆盖患者选择、ECMO临床管理、运行与后勤管理、伦理四个领域。

适用人群与场景

  • COVID-19相关重症ARDS需要静脉-静脉体外膜氧合(VV-ECMO)支持的患者。
  • 共识面向未来大流行中处理COVID-19相关重症ARDS ECMO争议问题的下一代ECMO从业者。

处置流程与药物剂量

  • 共识声明归入患者选择、ECMO临床管理、运行与后勤管理、伦理四个领域,具体推荐条款原文摘要未列出。

研究设计与关键结果

  • 制定机构为国际专家小组,科学委员会由5名主席组成,均具有超过5年ECMO经验和重症监护背景。
  • 专家基于ECMO临床经验(至少5年)和全球学术活动遴选,兼顾性别、地域、专业领域和资历多样性。
  • 第一阶段科学委员会获得52个关于COVID-19 ECMO争议主题的问题,第二阶段经重复和冗余审查后形成9个领域32个问题,验证率超过75%。
  • 第三阶段25个问题用于形成14条声明,6个问题未达成共识;第四阶段两轮投票后14条声明达成共识,归入患者选择、ECMO临床管理、运行与后勤管理、伦理四个领域。
  • 作者结论指出,COVID-19出现三年后对ECMO作用的理解已有进展但仍不完整。

证据类型、等级与局限

  • 证据类型:国际专家共识声明,采用改良德尔菲技术和名义组技术(NGT),经三轮面对面会议和匿名投票。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 共识旨在指导下一代ECMO从业者在未来大流行中处理COVID-19相关重症ARDS的ECMO争议问题。
  • 作者指出对COVID-19中ECMO作用的理解已有进展但仍不完整。

指南或共识出处

  • 专家共识声明:静脉-静脉体外膜氧合ECMO用于COVID-19重症ARDS:一项国际德尔菲研究(Ann Intensive Care)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The high-quality evidence on managing COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO) support is insufficient. Furthermore, there is little consensus on allocating ECMO resources when scarce. The paucity of evidence and the need for guidance on controversial topics required an international expert consensus statement to understand the role of ECMO in COVID-19 better. Twenty-two international ECMO experts worldwide work together to interpret the most recent findings of the evolving published research, statement formulation, and voting to achieve consensus.

OBJECTIVES: To guide the next generation of ECMO practitioners during future pandemics on tackling controversial topics pertaining to using ECMO for patients with COVID-19-related severe ARDS.

METHODS: The scientific committee was assembled of five chairpersons with more than 5 years of ECMO experience and a critical care background. Their roles were modifying and restructuring the panel's questions and, assisting with statement formulation in addition to expert composition and literature review. Experts are identified based on their clinical experience with ECMO (minimum of 5 years) and previous academic activity on a global scale, with a focus on diversity in gender, geography, area of expertise, and level of seniority. We used the modified Delphi technique rounds and the nominal group technique (NGT) through three face-to-face meetings and the voting on the statement was conducted anonymously. The entire process was planned to be carried out in five phases: identifying the gap of knowledge, validation, statement formulation, voting, and drafting, respectively.

RESULTS: In phase I, the scientific committee obtained 52 questions on controversial topics in ECMO for COVID-19, further reviewed for duplication and redundancy in phase II, resulting in nine domains with 32 questions with a validation rate exceeding 75% (Fig. 1). In phase III, 25 questions were used to formulate 14 statements, and six questions achieved no consensus on the statements. In phase IV, two voting rounds resulted in 14 statements that reached a consensus are included in four domains which are: patient selection, ECMO clinical management, operational and logistics management, and ethics.

CONCLUSION: Three years after the onset of COVID-19, our understanding of the role of ECMO has evolved. However, it is incomplete. Tota14 statements achieved consensus; included in four domains discussing patient selection, clinical ECMO management, operational and logistic ECMO management and ethics to guide next-generation ECMO providers during future pandemic situations.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Rabie AA, Elhazmi A, Azzam MH, et al. Expert consensus statement on venovenous extracorporeal membrane oxygenation ECMO for COVID-19 severe ARDS: an international Delphi study. Ann Intensive Care. 2023. PMID: 37129771. doi:10.1186/s13613-023-01126-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。